Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.

Articles Tagged with spinal cord injury

Published on:

spinal cord injuryThe medical practice of trying to avoid scar formation at the site of a spinal cord injury may indeed not be correct. Every year approximately 12,500 American will suffer a spinal cord injury and an estimated 276,000 people in the US are suffering from long term effects related to this injury. For decades the prevailing medical dogma was that that scars were preventing neuronal regrowth across the injured area but a newly released study says it is actually the opposite that happens. Scar forming cells called astrocytes may actually help nerve regrowth.  A study recently published in Nature and authored by  Mark A. AndersonJoshua E. BurdaYilong RenYan AoTimothy M. O’SheaRiki KawaguchiGiovanni CoppolaBaljit S. KhakhTimothy J. Deming & Michael V. Sofroniew found that   “scars may be a bridge and not a barrier towards developing better treatments for paralyzing spinal cord injuries.”

Read more in Medical News Today

Published on:

Spinal%20Cord%20Injury.jpgAfter a spinal cord injury, the assumption that it takes years for degenerative changes in the spinal cord and the brain to happen is incorrect. A study from the University of Zurich, Uniklinik Balgrist, and University College London (UCL), demonstrates that anatomical changes in the spinal cord and brain above the injury site may occur within 40 days of acute spinal cord injury.

The researchers followed 13 patients with acute spinal cord injuries and used a new type of neuroimaging protocol that can measure the extent of tissue loss in the spinal cord and the brain. Because they can display the effects of spinal cord injury treatments on the central nervous system, new neuroimaging protocols will also be extremely valuable in clinical trials of new treatments.